[Drug-induced neuroleptic malignant syndrome].
Jitsuiki
Hiroaki
H
Yamashita
Hidehisa
H
Kozuru
Toshiro
T
Yamawaki
Shigeto
S
D000978:Antiparkinson Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001342:Autonomic Nervous System Diseases / Q000139:chemically induced / Q000175:diagnosis; D003620:Dantrolene / Q000627:therapeutic use; D003937:Diagnosis, Differential; D018491:Dopamine Agonists / Q000627:therapeutic use; D004565:Electroconvulsive Therapy; D005334:Fever / Q000139:chemically induced / Q000175:diagnosis; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D011379:Prognosis; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects; D013577:Syndrome